SNCA and Parkinson disease: The present study was designed to detect the expression of α-synuclein through the peripheral nerves of the gastrointestinal tract and nerve plexuses in patients with PD, to verify the abnormal aggregation of α-synuclein in the peripheral nervous system, providing a biological marker for the early diagnosis of PD in the future.